Adhesion Deregulation in Acute Myeloid Leukaemia

Area of Science:

• Hematology
• Cell Biology
• Cancer Research

Background:

• Cell adhesion, mediated by cell adhesion molecules (AMs), is vital for normal hematopoiesis.
• Acute myeloid leukaemia (AML) involves aberrant cell adhesion, with AML blasts expressing AMs found on normal precursors.
• Differential AM expression in AML reflects disease heterogeneity and influences bone marrow processes.

Purpose of the Study:

• To explore the role of cell adhesion molecules (AMs) in acute myeloid leukaemia (AML).
• To investigate how AMs influence AML blast behavior within the bone marrow microenvironment.
• To highlight the prognostic significance and therapeutic potential of targeting AMs in AML.

Main Methods:

• Analysis of cell adhesion molecule (AM) expression in normal hematopoietic cells and AML blasts.
• Investigation of AM-mediated processes such as migration, homing, and quiescence in the bone marrow.
• Comparative analysis of AM roles in AML and potential parallels with epithelial-to-mesenchymal-transition.

Main Results:

• AML blasts express AMs, with differential expression compared to normal hematopoietic cells.
• AMs mediate AML blast homing to the bone marrow niche, conferring protection against chemotherapy.
• AML blasts can detach from niches and disseminate, similar to metastatic processes in solid cancers.

Conclusions:

• Cell adhesion molecules play a critical role in AML pathogenesis and progression.
• Targeting cell adhesion represents a promising therapeutic strategy for combating acute myeloid leukaemia.
• Understanding AM expression patterns can aid in predicting AML prognosis.